Panelists Question Efficacy, Immunogenicity Studies for Biosimilars
November 3rd 2020Certain biosimilar studies are performed out of an abundance of caution and good marketing sense, although science has leapfrogged the need for these trials, panelists said at the Terrapinn Festival of Biologics Basel 2020.
Need for Biosimilar Cooperation Among Hospitals, Infusion Centers, and Payers Is Identified
October 22nd 2020Overcoming biosimilar uptake barriers will take collaboration and policy change by hospitals, infusion clinics, and health plans, presenters said at the Academy of Managed Care Pharmacy Nexus 2020 Virtual conference.